Ghazale, Hussein <br/><br/>
Docosahexaenoic acid (DHA) enhances the therapeutic potential of neonatal neural stem cell transplantation post-Traumatic brain injury.  [electronic resource] 

 -  Behavioural brain research  03 2018 
 - 1-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7549 
<br/><br/><label>Standard No.: </label>10.1016/j.bbr.2017.11.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Brain--drug effects<br/>Brain Injuries, Traumatic--drug therapy<br/>Cells, Cultured<br/>Combined Modality Therapy<br/>Disease Models, Animal<br/>Docosahexaenoic Acids--pharmacology<br/>Dopaminergic Neurons--drug effects<br/>Doublecortin Protein<br/>Male<br/>Mice, Inbred C57BL<br/>Motor Activity--drug effects<br/>Neural Stem Cells--drug effects<br/>Neurogenesis--drug effects<br/>Neuroglia--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Random Allocation<br/>Recovery of Function--drug effects<br/>Stem Cell Niche<br/>Stem Cell Transplantation--methods